Amsacrine
Scheme
Prop.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XX01
CAS registry number (Chemical Abstracts Service)
0051264-14-3
Chemical Formula
C21-H19-N3-O3-S
Molecular Weight
393
Therapeutic Category
Antineoplastic agent: Acridine derivative
Chemical Name
Methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-
Foreign Names
- Amsacrinum (Latin)
- Amsacrin (German)
- Amsacrine (French)
- Amsacrina (Spanish)
Generic Names
- Amsacrine (OS: BAN, USAN, DCF)
- CI 880 (IS: Parke-Davis)
- m-AMSA (IS)
- Amsacrine Lactate (OS: BANM)
Brand Names
- Amekrin
NordMedica, Sweden - Amsacrine-Shenyang First Pharm
Shenyang First Pharmaceutical Factory, China - Amsidine
Goldshield, United Kingdom; Goldshield, Ireland; Goldshield, Malta; NordMedica, Netherlands; Pfizer, Belgium; Pfizer, New Zealand - Amsidyl
NordMedica, Germany; Pro Concepta Zug, Switzerland - Amsalyo
ProStrakan, France
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
